NCT00159952View on ClinicalTrials.gov

Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

November 30, 2007

Conditions
Severe SepsisSeptic Shock
Interventions
PROCEDURE

intensive insulin therapy

"control: glycemia will be controlled with insulin administration when higher than 215 mg/dL.~treatment: glycemia will be controlled with be controlled with insulin administration when higher than 110 mg/dL"

Trial Locations (3)

Unknown

"Hospital S.Paolo", Milan

Policlinico Hospital, Milan

"Hospital S.Gerardo", Monza

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Policlinico Hospital

OTHER

NCT00159952 - Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock | Biotech Hunter | Biotech Hunter